Gliadel Wafer and O6-Benzylguanine in Treating Patients With Recurrent Glioblastoma Multiforme

Clinical trial NCT00362921 · COMPLETED

Trial details

NCT number: NCT00362921
Sponsor: Duke University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Adult Brain Tumor

Start date: 2004-04-01
Primary completion: 2007-08-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.